Fresh from its first profit, Medcaptain steps into IPO spotlight 業績扭虧助攻 麥科田生物沖刺港股上市
The maker of medical devices crossed the profit threshold this year thanks to rising demand for its tools to diagnose digestive or urinary problems 在經歷多年虧損后，麥科田生物2025年上半年首次實現盈利，反映出公司營運效率提升，以及核心業務的穩健擴張。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.